Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 44 citing articles:

The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study
David Otiashvili, Tamar Mgebrishvili, Ada Beselia, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 39
Trends in drug use among nightclub and festival attendees in New York City, 2017-2022
Joseph J. Palamar, Austin Le, Charles M. Cleland, et al.
International Journal of Drug Policy (2023) Vol. 115, pp. 104001-104001
Open Access | Times Cited: 23
What is drug checking, anyway?
Monica J. Barratt, Fiona Measham
Drugs Habits and Social Policy (2022) Vol. 23, Iss. 3, pp. 176-187
Closed Access | Times Cited: 31
Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions
Olivia Price, Nicola Man, Rachel Sutherland, et al.
International Journal of Drug Policy (2023) Vol. 113, pp. 103976-103976
Open Access | Times Cited: 19
The Baltic and Nordic responses to the first Taliban poppy ban: Implications for Europe & synthetic opioids today
Jonathan P. Caulkins, Amund R. Tallaksen, Jirka Taylor, et al.
International Journal of Drug Policy (2024) Vol. 124, pp. 104314-104314
Open Access | Times Cited: 6
Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia
R. Brien, Isabelle Volpe, Jasmin Grigg, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Investigating the impact of COVID-19 on performance and image enhancing drug use
Matthew Dunn, Timothy Piatkowski
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 27
Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland
Eshan U. Patel, Suzanne M. Grieb, Abigail K. Winiker, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Fatal overdose: Predicting to prevent
Annick Bórquez, Natasha K. Martin
International Journal of Drug Policy (2022) Vol. 104, pp. 103677-103677
Open Access | Times Cited: 18
Temporal monitoring of stimulants during the COVID-19 pandemic in Belgium through the analysis of influent wastewater
Tim Boogaerts, Maarten Quireyns, Maarten De prins, et al.
International Journal of Drug Policy (2022) Vol. 104, pp. 103679-103679
Open Access | Times Cited: 15
The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia
Kasun Rathnayake, Paul A. Agius, Bernadette Ward, et al.
Addiction (2023) Vol. 118, Iss. 8, pp. 1557-1568
Open Access | Times Cited: 7
Factors associated with problematic substance use before and during the COVID-19 pandemic among a drug addiction recovery cohort: A prospective study in the Netherlands, Belgium, and UK
Thomas F. Martinelli, Gera E. Nagelhout, David Best, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 148, pp. 209025-209025
Open Access | Times Cited: 7
Changes in Online Illegal Drug Buying during COVID-19: Assessing Effects due to a Changing Market or Changes in Strain using a Longitudinal Sample Design
James E.Hawdon, Katalin Parti, Thomas E. Dearden
American Journal of Criminal Justice (2022) Vol. 47, Iss. 4, pp. 712-734
Open Access | Times Cited: 11
Drug consumption in German cities and municipalities during the COVID-19 lockdown: a wastewater analysis
Reinhard Oertel, Sara Schubert, Björn Helm, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 5, pp. 1061-1074
Open Access | Times Cited: 6
Opioid‐related ambulance attendances during the first 2 years of the COVID‐19 pandemic in Victoria, Australia
Michael McGrath, Mark Stare, Phyllis Chua, et al.
Addiction (2023) Vol. 119, Iss. 2, pp. 348-355
Open Access | Times Cited: 6
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic
Heather Bradley, Chelsea Austin, Sean T. Allen, et al.
International Journal of Drug Policy (2022) Vol. 110, pp. 103889-103889
Open Access | Times Cited: 10
General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns
Justine Perino, Hanta Ramaroson, Natalie Ong, et al.
International Journal of Drug Policy (2023) Vol. 118, pp. 104082-104082
Open Access | Times Cited: 5
Illicit Drug Use Patterns among Hospitalized Patients after the COVID-19 Pandemic and Economic Crisis
Ali Baran Tanrıkulu, Onur Koçhan
Bağımlılık Dergisi (2024) Vol. 25, Iss. 3, pp. 254-261
Open Access | Times Cited: 1
Drug use during the second year of the COVID-19 pandemic: observations from repeated cross-sectional surveys of sexual minority men in the US active on social networking applications
Tyrel J. Starks, Joseph R. Hillesheim, Juan Castiblanco, et al.
AIDS Care (2024) Vol. 36, Iss. sup1, pp. 145-153
Closed Access | Times Cited: 1
The impact of the COVID‐19 pandemic on calls to an alcohol and drug helpline in Victoria, Australia, for alcohol, methamphetamine and cannabis use concerns
Annette Peart, Jasmin Grigg, Christopher Greenwood, et al.
Drug and Alcohol Review (2024) Vol. 43, Iss. 7, pp. 2065-2076
Open Access | Times Cited: 1
Trace residue identification, characterization, and longitudinal monitoring of the novel synthetic opioid β‐U10, from discarded drug paraphernalia
Henry West, John Fitzgerald, Katherine Hopkins, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 9, pp. 1576-1586
Open Access | Times Cited: 8
3,4-Methylenedioxymethamphetamine quantification via benchtop 1H qNMR spectroscopy: Method validation and its application to ecstasy tablets collected at music festivals
Anca Frinculescu, Alexander F. G. Maier, Trevor Shine, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 214, pp. 114728-114728
Closed Access | Times Cited: 7
Recreational N2O use: just laughing or really bad news?
Jan van Amsterdam, Tibor M. Brunt, Ton Nabben, et al.
Addiction (2021) Vol. 117, Iss. 2, pp. 268-269
Open Access | Times Cited: 10
Increased Nicotine Consumption in Australia During the First Months of the COVID-19 Pandemic
Phong K. Thai, Benjamin J. Tscharke, Jake O’Brien, et al.
Nicotine & Tobacco Research (2023) Vol. 25, Iss. 6, pp. 1194-1197
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top